Walmart reaches settlement with U.S. DOJ over opioid prescription dispensing allegations

Walmart has agreed to settle a 2020 federal lawsuit alleging the retailer violated the Controlled Substances Act by improperly filling opioid prescriptions. While the financial terms remain undisclosed, the agreement resolves claims that the company contributed to the national opioid crisis. The settlement marks the conclusion of a multi-year legal dispute between the Department of Justice and the nation's largest retailer.